Protein requirements become critical Both menopause and GLP-1-induced weight loss put muscle mass at risk
For individuals with type 2 diabetes , impaired GLP-1 response is common, contributing to poor glycaemic control and weight gain
The clinical trials on melatonin range in duration from 10 days to 6 months
While muscle loss is standard with any diet or weight-loss regimen, loss of muscle on GLP-1s can be more dramatic, Ahmed says, causing what's been dubbed "Ozempic face," a bonier, looser-skinned look, where the muscle loss is particularly noticeable
Raman B, Cassar MP, Tunnicliffe EM, Filippini N, Griffanti L, Alfaro-Almagro F, et al